Tuberous Sclerosis Complex and Seizures “Knowledge is Power”

Slides:



Advertisements
Similar presentations
NEUROCUTANEOUS SYNDROMES
Advertisements

Neurocutaneous Disorders
Neurofibromatosis and Seizures “Knowledge is Power”
John Kanu UVA School of Medicine
Hussein Morfeq, MD Department of Ophthalmology King Abdulaziz University Hospital Jeddah, Saudi Arabia.
Case Report # [] Submitted by:Ladi Oki, MSIV Faculty reviewer:Dr. Sandra Oldham, MD Date accepted:28 September 2011 Radiological Category:Principal Modality.
Evan Fertig Director of Research Director of NEREG Dravet Program Northeast Regional Epilepsy Group.
TSC2 and Tuberous Sclerosis Complex Disease Laura Koontz Biology 169.
Sara M. Koenig, MD Wilson B. Altmeyer, MD Carlos Bazan III, MD Maria P. Valencia, MD.
The Kidney in Tuberous Sclerosis Robert Isom, MD Clinical Associate Professor Stanford University School of Medicine.
MADILYN RAE LENS Born 10/19/2012 Heather Lens After a day of labor, Madilyn finally decided to grace us with her presence.
Autism and Epilepsy: A Comprehensive Medical Approach
Diagnosis and Treatment of Epilepsy Marcelo E. Lancman, M.D. Director, Epilepsy Program NEREG.
Case Report # 1 Submitted by: 29 August, 2007 Faculty reviewer: Date accepted: Radiological Category:Principal Modality (1): Principal Modality (2): Neuroradiology.
Médecine en mutation dans une société en mutation: Nouveautés en Épilepsie L CARMANT SAINTE-JUSTINE HOSPITAL UNIVERSITY OF MONTREAL.
Not all babies are well babies. Case 1 You are seeing a healthy appearing 1 day old term AGA female infant who had a cyanotic/choking episode overnight.
Pediatric Dermatology August 2014
Neurocutaneous syndromes Dr. Ibrahim Khasraw Lecturer in Pediatrics School of Medicine Sulaimani University of.
Tuberous Sclerosis and Behavior Neuroscience Case Conference August 11, 2006.
Control # 848 Title: “Polkadots and Moonbeams” Neurocutaneous Syndromes Made Easy eEdE# eEdE-197.
WELCOME TO THE NEW YORK TSC CONFERENCE May 5, 2013.
Emerging Treatment Strategies for Tuberous Sclerosis Complex
November 25, 2008 Neurology Board Review. Neurocutaneous Syndromes.
Summit on Drug Discovery Tuberous Sclerosis Alliance July 7, 2011 Biomarkers in TSC and LAM.
HOUSE M.D. DECODED. The FIVE O Tuberous sclerosis O Kawasaki’s Disease O Histiocytosis O Erdheim-Chester Disease O Lymphoma.
Sergei Kashirny, MD LSU Neurology February, 3, 2011.
Introduction Tuberous sclerosis complex (TSC) is an autosomal dominant multisystem disorder characterized by hamartomas in multiple organ systems, including.
Tumors  Gliomas  Neuronal tumors  Poorly differentiated neoplasms  Other parenchymal tumors  Meningiomas  Paraneoplastic syndromes  Peripheral.
Bruce R. Wall, MD, FACP February 2nd,  “I never questioned the integrity of an umpire… their eyesight, yes…” Leo Durocher  “About the only problem.
Case Report # 1 Submitted by:Keith Pettibon Faculty reviewer:Sandra Oldham, MD Date accepted:24 August 2010 Radiological Category:Principal Modality (1):
Case Study 65 Kenneth Clark, MD. Question 1 This is a 62-year-old man with a history of mild mental retardation and bilateral renal angiomyolipomas. A.
FIG.1 FIG.2 FIG.3. Fig.4Fig.5Fig.6 Fig.7 Fig.8 Fig 9 Fig.10 Fig.11 Fig.12.
Path 822: Experimental Cancer Diagnostics & Therapeutics: PATHOLOGY OF TUMOURS Sandip SenGupta, M.D. Professor of Pathology September 2005.
LAFAYETTE HOME HOSPITAL: EPILEPSY; 2004 LAFAYETTE HOME HOSPITAL: EPILEPSY; 2004.
Lennox Gastaut Syndrome Enrique Feoli MD North East Regional Epilepsy Group.
TSC1 and Facial Angiofibromas
Case Study 10 Harry Kellermier, M.D.. The patient is a 27-year-old female with a history of complex partial seizures starting at age 16. A typical episode.
GENODERMATOSES DR. HADAF ABDULAMIR. ICTHYOSES A group of disorders where the homeostatic mechanism of epidermal cell kinetics or differentiation is altered,
Daniela LONGO Bologna, October 6, 2010.
TSC1/Hamartin and Facial Angiofibromas Biology 169 Ann Hau.
NEUROCUTANEOUS SYNDROME
Tuberous Sclerosis Complex Criteria and Surveillance
Tuberous Sclerosis Abdullah M. Al-Olayan MBBS, SBP, ABP
Epilepsy in TSC Kevin C. Ess, MD, PhD Vanderbilt Children’s Hospital Vanderbilt Brain Institute Vanderbilt Center for Stem Cell Biology Vanderbilt University.
TSC1 Tuberous Sclerosis 1
Congenital syndromes of malignancy with cutaneous features
Imaging of Epilepsy Ali Jassim Alhashli Year IV – Unit VIII (CNS) – Problem 6.
The role of the specialist TS clinic
Transition from Pediatric to Adult Care
Current Challenges in care of patients with Tuberous Sclerosis Complex
MB Callaghan, DE Donnelly, PJ Morrison
Skin Manifestations of Tuberous Sclerosis Complex
Chapter 27 Epilepsy Overview Signs and symptoms
Potatoes? Tuberculosis? Cancer? not quite...
Volume 8, Issue 4, Pages (April 2017)
PHACOMATOSES 1. Neurofibromatosis
FACILITATING DRUG DEVELOPMENT FOR TUBEROUS SCLEROSIS COMPLEX
INTRODUCTION AIMS POPULATION AND METHODS RESULTS CONCLUSIONS
Managing the Patient With Tuberous Sclerosis Complex
Case Study 65 Kenneth Clark, MD.
Tuberous Sclerosis TSC2/ Tuberin Alison Chappell.
TSC1 in Facial Angiofibromas
Volume 49, Issue 6, Pages (December 2013)
Tuberous Sclerosis Complex Fundamental Concepts in Diagnosis and Management.
Volume 63, Pages 6-22 (October 2016)
NEUROCUTANEOUS MARKERS
NEUROCUTANEOUS DISORDERS AND SYNDROMES
Volume 21, Issue 4, Pages (November 2003)
Presentation transcript:

Tuberous Sclerosis Complex and Seizures “Knowledge is Power” Stephen J. Thompson, MD Chief, Pediatric Neurology Director, Pediatric Neuro-Oncology Hackensack University Medical Center

What is TCS? Neurocutaneous disorder TSC: Neurologic structures and skin are derived from the same tissue in the embryo TSC: Bourneville’s Bisease Skin, brain, kidneys, heart…

How and Why? TCS1 (9q24) and TSC2 (16p13) Hamartin TSC2 Tuberin mTOR Involves abnormal cellular differentiation, proliferation, and migration Can affect every organ system in the body 1 of 10,000

TSC Diagnostic Criteria-1 1998 Consensus Conference Major and Minor Criteria A combination of findings is required No one finding can make the diagnosis

TSC Diagnostic Criteria-2 Definite TSC: Either 2 major features or 1 major feature with 2 minor features Probable TSC: One major feature and one minor feature Possible TSC: Either 1 major feature or 2 or more minor features

TSC: Major Features Facial angiofibromas or forehead plaque Non-traumatic ungual or periungual fibroma Hypomelanotic macules (more than three) Shagreen patch (connective tissue nevus) Multiple retinal nodular hamartomas Cortical tuber Subependymal nodule Subependymal giant cell astrocytoma Cardiac rhabdomyoma, single or multiple Lymphangiomyomatosis Renal angiomyolipoma

TSC Minor Features Multiple randomly distributed pits in dental enamel Hamartomatous rectal polyps Bone cysts Cerebral white matter migration lines Gingival fibromas Non-renal hamartoma Retinal achromic patch "Confetti" skin lesions Multiple renal cysts

TSC Clinical Issues Skin Heart Kidneys Lungs, and teeth Brain and eyes: Seizures Cognitive/Academic/Developmental issues Subependymal nodules SEGA Headaches/Hydrocephalus

Seizures in TSC Age related Infantile spasms Lennox-Gastaut Syndrome Partial complex seizures Generalized seizures.

Infantile Spasms 1 in 2000 children overall but as many as 40% of children with TSC Specific clinical presentation Specific EEG findings Treatment: ACTH, oral corticosteroids Zonegran, Topamax TSC Vigabatrin

Other Seizures in TSC Partial complex seizures Generalized Seizures Trileptal, Vimpa,t etc… Generalized Seizures Keppra, Dilantin, Depakote, etc… Novel therapy Ketogenic Diet

Tumors in TSC: SEGA SEGA Location Presentation: Subependymal giant cell astrocytoma Location Foramen of Monroe Presentation: Headaches Hydrocephalus

SEGA Treatment Surgical resection Chemotherapy Novel agent, AFINITOR (everolimus) mTOR inhibitor mTOR is inactivated in TSC AFINITOR can treat: SEGA AML Adenoma sebaceum Seizures?

Resources Tuberous Sclerosis Alliance TS Center at NEREG/HUMC www.tsalliance.org TS Center at NEREG/HUMC